Category: National Institutes of Health

Has Your Scientific Work Been Cut? We Want to Hear.

For a new series, Times journalists are speaking with scientists whose research has ended as a result of policy changes by the Trump administration.
Study Undercuts Idea That Cash Payments to Poor Families Help Child Development

Rigorous new research appears to show that monthly checks intended to help disadvantaged children did little for their well-being, adding a new element to a dispute over expanded government aid.
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments

The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have resulted in blindness, tumors and other injuries.
Nine Federally Funded Scientific Breakthroughs That Changed Everything

The U.S. is slashing funding for scientific research, after decades of deep investment. Here’s some of what those taxpayer dollars created.
Trump Administration Cancels Scores of Grants to Study Online Misinformation

Federal agencies say that by axing the funding they are protecting the First Amendment. Critics see it as stifling scientific inquiry into sources of harmful online content.
Top N.I.H. Official Abruptly Resigns as Trump Orders Deep Cuts

Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.
Republicans Love Trump’s Spending Cuts. Just Not in Their States.

Even as they praise the president’s unilateral actions to slash federal spending, G.O.P. lawmakers have quietly moved to seek carve outs or exemptions for their own constituents.
Five Ways R.F.K. Jr. Could Undermine Lifesaving Childhood Vaccines

If he is confirmed as H.H.S. secretary, the longtime vaccine critic would be in a position to change the government’s immunization recommendations and delay the development of new vaccines.
Embattled Alzheimer’s Researcher Is Charged With Fraud

Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
U.S. Lags Behind Other Countries in Hepatitis-C Cures

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval.
Alcohol-Related Deaths Surge to Nearly 500 a Day, CDC Says

Spikes of fatalities linked to drinking that began with the Covid pandemic were not an anomaly. An estimated 178,000 people died in 2021 from similar causes.
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.